Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force

被引：21

作者：

Butterfield, Lisa H. ^{[3
,4
]}

Disis, Mary L. ^{[5
]}

Khleif, Samir N. ^{[6
]}

Balwit, James M. ^{[7
]}

Marincola, Francesco M. ^{[1
,2
]}

机构：

[1] NIH, IDIS, Dept Translat Med, Ctr Clin, Bethesda, MD 20892 USA

[2] NIH, CHI, Bethesda, MD 20892 USA

[3] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA

[4] Univ Pittsburgh, Dept Surg & Immunol, Pittsburgh, PA USA

[5] Univ Washington, Tumor Vaccine Grp, Div Oncol, Seattle, WA 98195 USA

[6] NCI, Canc Vaccine Sect, NIH, Bethesda, MD 20892 USA

[7] Soc Immunotherapy Canc & Execut Director Inc, Milwaukee, WI USA

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2010年 / 8卷

关键词：

OVARIAN-CANCER; T-CELLS; SURVIVAL; LYMPHOCYTES;

D O I：

10.1186/1479-5876-8-130

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) hosted a one-day symposium at the National Institutes of Health on September 30, 2010 to address development and application of biomarkers in cancer immunotherapy. The symposium, titled Immuno-Oncology Biomarkers 2010 and Beyond: Perspectives from the iSBTc/SITC Biomarker Task Force, gathered approximately 230 investigators equally from academia, industry and governmental/regulatory agencies from around the globe for panel discussions and presentations on the following topics: 1) immunologic monitoring: standardization and validation of assays; 2) correlation of immunity to biologic activity, clinical response and potency assays; 3) novel methodologies for assessing the immune landscape: clinical utility of novel technologies; and 4) recommendations on incorporation of biomarkers into the clinical arena. The presentations are summarized in this report; additional program information and slides are available online at the iSBTc/SITC website.

引用

页数：8

共 15 条

[11] Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer [J].

Sato, E ;

Olson, SH ;

Ahn, J ;

Bundy, B ;

Nishikawa, H ;

Qian, F ;

Jungbluth, AA ;

Frosina, D ;

Gnjatic, S ;

Ambrosone, C ;

Kepner, J ;

Odunsi, T ;

Ritter, G ;

Lele, S ;

Chen, YT ;

Ohtani, H ;

Old, LJ ;

Odunsi, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) :18538-18543

[12] Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology [J].

Tahara, Hideaki ;

Sato, Marimo ;

Thurin, Magdalena ;

Wang, Ena ;

Butterfield, Lisa H. ;

Disis, Mary L. ;

Fox, Bernard A. ;

Lee, Peter P. ;

Khleif, Samir N. ;

Wigginton, Jon M. ;

Ambs, Stefan ;

Akutsu, Yasunori ;

Chaussabel, Damien ;

Doki, Yuichiro ;

Eremin, Oleg ;

Fridman, Wolf Herve ;

Hirohashi, Yoshihiko ;

Imai, Kohzoh ;

Jacobson, James ;

Jinushi, Masahisa ;

Kanamoto, Akira ;

Kashani-Sabet, Mohammed ;

Kato, Kazunori ;

Kawakami, Yutaka ;

Kirkwood, John M. ;

Kleen, Thomas O. ;

Lehmann, Paul V. ;

Liotta, Lance ;

Lotze, Michael T. ;

Maio, Michele ;

Malyguine, Anatoli ;

Masucci, Giuseppe ;

Matsubara, Hisahiro ;

Mayrand-Chung, Shawmarie ;

Nakamura, Kiminori ;

Nishikawa, Hiroyoshi ;

Palucka, A. Karolina ;

Petricoin, Emanuel F. ;

Pos, Zoltan ;

Ribas, Antoni ;

Rivoltini, Licia ;

Sato, Noriyuki ;

Shiku, Hiroshi ;

Slingluff, Craig L. ;

Streicher, Howard ;

Stroncek, David F. ;

Takeuchi, Hiroya ;

Toyota, Minoru ;

Wada, Hisashi ;

Wu, Xifeng .

JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7

[13]

U. S. Food and Drug Administration, VACC BLOOD BIOL

[14] Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer [J].

Zhang, L ;

Conejo-Garcia, JR ;

Katsaros, D ;

Gimotty, PA ;

Massobrio, M ;

Regnani, G ;

Makrigiannakis, A ;

Gray, H ;

Schlienger, K ;

Liebman, MN ;

Rubin, SC ;

Coukos, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03) :203-213

[15]

DRAFT GUIDANCE I POT

← 1 2 →